These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38826697)

  • 1. Evidence Construction of Chuankezhi Injection Against Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Pharmacology.
    Wei X; Zhong Y; Yi X; Li T; Ling Z; Ming M; Zhang S; He Z
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1177-1196. PubMed ID: 38826697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of Chuankezhi injection in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis protocol.
    Zhou Z; Zheng W; Liang T; Yan Q; Zhang C; Huang H; Liu X; Ye X
    Medicine (Baltimore); 2020 Jan; 99(2):e18620. PubMed ID: 31914041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systematic review of Chuankezhi injection for treating acute exacerbation of chronic obstructive pulmonary disease].
    Chen SQ; Yang XY; Tang XY; Li M; Liu S; Liang J; Zhang XY; Shang HC
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(14):2789-2795. PubMed ID: 29098839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chuankezhi injection for asthma: Protocol of a systematic review and meta-analysis.
    Li M; Zheng W; Zhang C; Yan Q; Peng Z; Xie F; Hong Y; Liu X
    Medicine (Baltimore); 2019 Aug; 98(33):e16630. PubMed ID: 31415356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.
    Xie S; Yan P; Yao C; Yan X; Huo Y; Zhang J; Liu S; Feng Z; Shang H; Xie L
    Trials; 2019 Feb; 20(1):136. PubMed ID: 30777117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shengmai injection as an adjunctive therapy for the treatment of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Huang X; Duan X; Wang K; Wu J; Zhang X
    Complement Ther Med; 2019 Apr; 43():140-147. PubMed ID: 30935521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Network Meta-analysis of 3 kinds of Chinese medicine injections in treatment of acute exacerbations of chronic obstructive pulmonary disease].
    Zhu XY; Xie HF; Han H; Gao F
    Zhongguo Zhong Yao Za Zhi; 2019 May; 44(10):2179-2184. PubMed ID: 31355578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese oral herbal paste for the treatment of stable chronic obstructive pulmonary disease: Protocol for a systematic review and meta-analysis.
    Zeng Y; Li Y; Wei H; Xiong C; Liao L; Miao TW; Mao B; Fu JJ
    Medicine (Baltimore); 2019 Jul; 98(28):e16444. PubMed ID: 31305473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the efficacy and pharmacological mechanism of Danhong injections for treating chronic obstructive pulmonary disease: A PRISMA-compliant meta-analysis and network pharmacology analysis.
    Gao X; Gao J
    Medicine (Baltimore); 2023 Feb; 102(5):e32846. PubMed ID: 36749263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD.
    Zhao P; Li J; Li Y; Tian Y; Wang Y; Zheng C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2633-56. PubMed ID: 26674991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and safety of Chinese herbal medicine versus placebo for the treatment of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Xiong C; Li Y; Zhuang G; Zeng Y; Wei H; Li C; Li L; Liao L; Fu J
    Complement Ther Med; 2021 Jun; 59():102691. PubMed ID: 33618010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness and Safety of Seven Qi-Tonifying Chinese Medicine Injections for AECOPD Patients: A Systematic Review and Network Meta-Analysis.
    Deng X; Kang F; Chen X; Lai J; Guan X; Guo X; Liu S
    Evid Based Complement Alternat Med; 2021; 2021():6517515. PubMed ID: 34819982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review and meta-analysis of the herbal formula Buzhong Yiqi Tang for stable chronic obstructive pulmonary disease.
    Chen Y; Shergis JL; Wu L; Yu X; Zeng Q; Xu Y; Guo X; Zhang AL; Xue CC; Lin L
    Complement Ther Med; 2016 Dec; 29():94-108. PubMed ID: 27912964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese Herbal Medicine Versus Placebo for the Treatment Of Chronic Obstructive Pulmonary Disease: A Protocol of Systematic Review and Meta-analysis.
    Xiong C; Li Y; Zeng Y; Wei H; Zhuang GT; Li L; Zhao LH; Li CY; Qin EQ; Fu JJ
    Medicine (Baltimore); 2019 Aug; 98(35):e17002. PubMed ID: 31464955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel strategy to reveal clinical advantages and molecular mechanism of aidi injection in the treatment of pancreatic cancer based on network meta-analysis and network pharmacology.
    Wang H; Wu Z; Liu Y; Wang M; Stalin A; Guo S; Li J; Wu C; Zhang J; Tan Y; Huang Z; Lu S; Fan X; Wu J
    J Ethnopharmacol; 2022 Mar; 285():114852. PubMed ID: 34838619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese Medical Injections for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Network Meta-analysis.
    Hu H; Ji Z; Qiang X; Liu S; Sheng X; Chen Z; Liu F; Wang H; Zhang J
    Int J Chron Obstruct Pulmon Dis; 2021; 16():3363-3386. PubMed ID: 34949918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network Pharmacology and Experimental Verification Reveal the Regulatory Mechanism of Chuanbeimu in Treating Chronic Obstructive Pulmonary Disease.
    Xian M; Xu J; Zheng Y; Zhang L; Zhao J; Chen J; Li S; Lin L; Zhong Y; Yang Z; Xie T; Huang L; Ding Y
    Int J Chron Obstruct Pulmon Dis; 2024; 19():799-813. PubMed ID: 38529478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of Action of Bu-Fei-Yi-Shen Formula in Treating Chronic Obstructive Pulmonary Disease Based on Network Pharmacology Analysis and Molecular Docking Validation.
    Wu L; Chen Y; Yi J; Zhuang Y; Cui L; Ye C
    Biomed Res Int; 2020; 2020():9105972. PubMed ID: 33313323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of Jianpiyifei II granules in the treatment of chronic obstructive pulmonary disease: Network pharmacology analysis, molecular docking, and experimental assessment.
    Xie D; Quan J; Yu X; Liang Z; Chen Y; Wu L; Lin L; Fan L
    Phytomedicine; 2024 Apr; 126():155273. PubMed ID: 38342020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.